SELENIUM-CONTAINING ISOXAZOLAMINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
申请人:SHANGHAI XINGYE PHARMACEUTICAL TECHNOLOGY CO., LTD
公开号:US20210292315A1
公开(公告)日:2021-09-23
The present invention disclosed a series of novel selenium-containing isoxazolamine derivatives as shown in formula I, which could regulate the generation and/or activity of TNF-α and ferroptosis-like cell death. The present invention also disclosed the preparation method and the use thereof in preparing a drug for treating the diseases mediated by TNF-α and/or iron-dependent cell death.
本发明揭示了一系列新颖的含硒异噁唑胺衍生物,如公式I所示,可以调节TNF-α的产生和/或活性以及类铁死亡。本发明还揭示了制备方法以及将其用于制备用于治疗由TNF-α和/或铁依赖性细胞死亡介导的疾病的药物。